Probiotic shows promise for long COVID blood vessel damage
NCT ID NCT05227170
First seen May 02, 2026 · Last updated May 15, 2026 · Updated 4 times
Summary
This study tests whether a probiotic called Lp299v can improve blood vessel function in people with long COVID (PASC). The trial involves 80 adults who had COVID-19 in the past 30-180 days and now have long COVID symptoms. Researchers will measure blood vessel health using ultrasound and other tests to see if the probiotic reduces inflammation and improves circulation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID - 19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Medical College of Wisconsin
Milwaukee, Wisconsin, 53226, United States
Conditions
Explore the condition pages connected to this study.